NASDAQ
Aquestive Therapeutics, Inc. (AQST) has a fcf yield of -6.73% as of Monday, August 3, 2026. This represents a 60.71% increase compared to its 12-month average of -17.12%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.